|
Scientists Without Borders visits the NYSE to celebrate its launch. In honor of the occasion, President of the New York Academy of Sciences Ellis Rubinstein rings The Opening BellSM.
Scientists Without Borders is a new web-based initiative designed to match the needs of scientists and organizations in developing countries with the resources available from scientists and organizations in the developed world.
Joining the Opening Bell ceremony are: Praveen Tyle (CSO of Bausch & Lomb), Henrik Sandvad Rasmussen (Vice President, Clinical Research, Medical and Regulatory Affairs, Novo Nordisk), Brian Fergusen (Professor of Anthropology, Rutgers University and member of the NYAS Board of Directors), Mohammed Hassan (Executive Director, Academy of Sciences for the Developing World), Eugene Terry (Former Director General of the West Africa Rice Development Association), Judi Wakhungu (Executive Director, African Centre for Technology Studies) George T. De Sanctis (Director, Strategy and Open Innovation Research and Development, Sanofi Aventis), Jana Armstrong (Executive Director, DNDi North America), Shirley Strum Kenny (President, Stony Brook University), Michael Whitehouse (Executive Director, Vital Venture Networks), Evelyn Strauss (Executive Director, Scientists Without Borders), Rene Baston (Vice President of Business Development, NYAS) and Lori Warrens (Executive Director, Partnership for Quality in Medical Donations, PQMD).
Click the link below to view an archived webcast of The Opening Bell.
 Windows Media Player 300k
Scientists Without Borders
Scientists Without Borders is a new online initiative to link and mobilize institutions and individuals who use science to improve quality of life in developing countries. Whether exploring low-cost green energy technologies, improving strategies for sustainable agriculture, or developing tools to prevent and treat disease, science builds knowledge that enhances health and prosperity.
Conceived by the New York Academy of Sciences and the United Nations Millennium Project, Scientists Without Borders is a simple yet powerful internet database that offers new opportunities for international collaboration. Scientists Without Borders will give its members the power to join forces across organizations, disciplines and distances to match needs with resources and benefit the world’s poorest citizens.
Scientists Without Borders is backed by many NYSE-listed companies, including founding supporter, Merck & Co., Inc. (NYSE: MRK), as well as major supporters GlaxoSmithKline (NYSE: GSK), Pfizer Inc. (NYSE: PFE), Novo Nordisk A/S (NYSE: NVO), Johnson & Johnson (NYSE: JNJ), Novartis (NYSE: NVS), Abbott Laboratories (NYSE: ABT), Schering-Plough Corporation (NYSE: SGP ) and other leading companies.
|
